New treatment cuts cancer rates

Published December 13, 2007 5:00am ET



Combining chemotherapy, radiation and surgery tripled the survival of stage III lung cancer patients to 45 percent, say St. Joseph Medical Center doctors, who hope to replicate their success nationwide.

Fighting the cancer with weekly doses of chemotherapy and daily radiation can shrink cancerous tissue to levels that make surgery feasible, said Dr. Mark Krasna, thoracic surgeon and medical director of the Cancer Institute at St. Joseph in Towson.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.